Amit Gupta, Ph.D. is the Computational Chemist for the Texas Medical Center’s Accelerator for Cancer Therapeutics (TMC|ACT).
Amit is passionate about drug discovery and science strategy in hopes of ultimately helping patients in need. Though he is trained as a computational chemist and has extensive experience in computational ligand and target-based drug design approaches, he is also well versed in experimental biophysical and biochemical assays. He has an 8+ year track record of success in big pharma and academic environments through learning and implementing computer-aided drug design (CADD) and medicinal chemistry intuition and taking the designs to the bench. Amit’s previously held roles include Scientist at AstraZeneca, and postdoctoral fellow at Ewha Woman’s University in South Korea, UT Health Science Center at Houston and University of Houston.
Amit obtained his Ph.D. degree from one of India’s national laboratories, CSIR-central drug research institute (CDRI) and his research activities are well documented in more than 22 peer-reviewed publications and patents in the fields of medicinal chemistry and drug discovery.